10-Q: Formation Minerals Reports Q1 2025 Results, Completes Reverse Merger and Shifts Focus to Energy Assets

Formation Minerals, formerly SensaSure Technologies, reports a net income of $264,770 for the quarter ending July 31, 2024, following a reverse merger and a strategic shift to energy assets.

Summary

• Formation Minerals, previously known as SensaSure Technologies, completed a reverse merger with Verde Bio Holdings, shifting its focus from medical technology to energy assets.
• The company reported a net income of $264,770 for the quarter ended July 31, 2024, a significant turnaround from a net loss of $336,648 in the same period last year.
• This quarter's positive results were primarily driven by a gain of $1,043,542 from the extinguishment of warrant liabilities.
• Revenue for the quarter was $36,139, down from $75,694 in the prior year, due to lower oil and gas production and the sale of some mineral properties.
• Operating expenses totaled $728,801, including $365,775 in professional fees, reflecting costs associated with the merger.
• The company's working capital deficit increased to $2,460,908 from $2,384,793 at the end of the previous quarter.
• As of September 20, 2024, the company had 91,380,533 shares of common stock outstanding.
• The company is actively seeking additional financing to support its operations and growth.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While the company achieved a positive net income and completed a strategic merger, it also faces significant challenges, including a working capital deficit, high operating expenses, and internal control weaknesses. The shift to energy assets is a positive move, but the company's financial stability remains a concern.

Positives

• The company achieved a net income of $264,770 for the quarter, a significant improvement from the previous year's loss.
• The reverse merger with Verde Bio Holdings has positioned the company in the energy sector.
• The extinguishment of warrant liabilities resulted in a substantial gain of $1,043,542.
• The company has secured additional financing through the issuance of a promissory note and preferred stock.
• The company is actively managing its portfolio, selling non-core assets to reinvest in higher-growth areas.

Negatives

• The company's revenue decreased to $36,139 from $75,694 in the same quarter last year.
• Operating expenses increased to $728,801, primarily due to merger-related costs.
• The company's working capital deficit increased to $2,460,908.
• The company has an accumulated deficit of $20,000,176.
• The company's cash position decreased to zero as of July 31, 2024.

Risks

• The company's ability to continue as a going concern is dependent on securing additional financing and generating profitable operations.
• The company's working capital deficit raises concerns about its short-term financial stability.
• The company's reliance on debt and equity financing may lead to dilution of existing stockholders.
• The company's internal controls over financial reporting are considered ineffective, which could lead to material misstatements in future financial statements.
• The company is exposed to market risks related to oil and gas prices.

Future Outlook

The company is focused on acquiring and exploiting upstream energy assets, specifically targeting oil and gas mineral interests, oil and gas royalty interests and select non-operated working interests. Management expects new opportunities in the oil, gas and mineral industries, increasing the company's presence and reputation in the energy space. The company is also actively managing its portfolio to maximize stockholder value, including by identifying potential sales of non-core assets to allow for the reinvestment of those proceeds into the higher growth areas.

Management Comments

• Management believes that the current business of commercializing the exhale breath technology patents was no longer feasible.
• Management sought to establish a new business segment to develop energy related businesses.
• Management expects new opportunities in the oil, gas and mineral industries.
• Management believes that new oil and gas development assets have been added to the company's portfolio.
• Management continues to actively manage its portfolio to maximize stockholder value.

Industry Context

The company's shift from medical technology to energy aligns with a broader trend of companies diversifying into sectors with higher growth potential. The acquisition of oil and gas assets positions the company to capitalize on the current energy market dynamics. The company is now competing with other small to medium sized oil and gas exploration and production companies.

Comparison to Industry Standards

• The company's revenue of $36,139 is significantly lower than the average revenue of comparable small-cap oil and gas companies, which typically range from $1 million to $10 million per quarter.
• The company's net income of $264,770 is unusual for a company of this size in the oil and gas sector, as many smaller companies are still in the exploration and development phase and are not yet profitable. The gain on extinguishment of warrant liabilities is a one-off event and not indicative of ongoing profitability.
• The company's operating expenses of $728,801 are higher than average for a company of this size, primarily due to merger-related costs. Comparable companies typically have lower operating expenses as a percentage of revenue.
• The company's working capital deficit of $2,460,908 is a significant concern, as it indicates a lack of short-term liquidity. Many comparable companies have positive working capital.
• The company's reliance on debt and equity financing is common for small-cap oil and gas companies, but the company's high debt levels and negative cash flow from operations are concerning.
• The company's internal control weaknesses are a significant concern, as they could lead to material misstatements in future financial statements. Comparable companies typically have more robust internal controls.
• The company's shift from medical technology to energy is a significant strategic change, and it is difficult to compare the company to its previous peers in the medical technology sector. The company is now competing with other small to medium sized oil and gas exploration and production companies.

Related Party Transactions

• The company owed $144,564 to the President and Chief Executive Officer for loans.
• The company had a balance of demand loans in the amount of $129,279 from a principal stockholder.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of additional shares.
• Employees may be affected by the company's restructuring and shift in focus.
• Customers of the previous medical technology business will no longer be served.
• Suppliers and creditors may be impacted by the company's financial instability.

Next Steps

• The company is working to secure financing to complete the acquisition of oil and gas properties.
• The company is actively managing its portfolio to maximize stockholder value.
• The company plans to increase personnel resources and technical accounting expertise within the accounting function.
• The company plans to recruit and appoint one or more outside directors to its board of directors who shall be appointed to an audit committee.

Key Dates

Keywords

Formation Minerals, Verde Bio Holdings, reverse merger, energy assets, oil and gas, mineral interests, royalty interests, financial results, warrant liabilities, capital raise